2 hours ProKidney (NASDAQ:PROK) Coverage Initiated by Analysts at JPMorgan Chase & Co. MarketBeat
JPMorgan Chase & Co. started coverage on shares of ProKidney in a research report on Monday. They issued a “neutral” rating for the company.
JPMorgan (JPM) · Nasdaq 100 · Science